Even before Aleafia Health (TSX: ALEF) (OTCQX: ALEAF) (FRA: ARAH) acquired Emblem it was worth $6.50 according to Mackie Research. It seems that the market is adjusting to the newly-formed entity and the loose hands are being shaken out as ALEF sits firmly at $1.50 (representing 333% in implied upside).
Now, with Emblem under the asset umbrella and the stock at a severe discount to that price target, ALEF appears to be a steal.
Just the newly announced expansion of ALEF’s extraction facility is worth more than all of Aleafia at current prices based on using the comparison of MediPharm Labs (TSXV: LABS) (OTCQB: MLCPF). ALEF’s oil extraction and spray/ oil/ capsule manufacturing facility is larger than MediPharm’s, but has the same market value– MediPharm has no cultivation, products, retail distribution, patients or clinics– ALEF does. Something is out of whack and should adjust appropriately in due time.
We suspect Mackie will update their research to reflect the combined value of Aleafia and Emblem and should include some sort of bump for cost savings operating them as one instead of two (1+1=3).
We suggest taking a closer look at Aleafia Health (TSX: ALEF) (OTCQX: ALEAF) (FRA: ARAH) at this juncture as they are ready to switch on the lights at their huge Niagara greenhouse that can grow 40,000,000 grams yearly; start planting at their huge, ultra-low-cost of production outdoor facility in Port Perry, ON that can grow 60,000,000 grams yearly; and they ramp up to the full 100,000,000 grams of capacity at their Paris, ON extraction and manufacturing facility (all pending proper approvals, expected any day).
Each one of these catalysts puts Aleafia at the precipice of an enormous shift upwards in theoretical value.
To learn more about Aleafia Health visit the company’s website here.
Investors who are interested in learning more click here.
Aleafia Health Inc. is a paid client of The Cannabis Investor.
This report/release/profile is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation unless otherwise stated below.